The role of IL-18 in type 1 diabetic nephropathy: The problem and future treatment

This publication has 103 references indexed in Scilit:

• Inflammation in Diabetic Nephropathy
  Mediators of Inflammation, 2012
• Quercetin and Allopurinol Ameliorate Kidney Injury in STZ-Treated Rats with Regulation of Renal NLRP3 Inflammasome Activation and Lipid Accumulation
  PLOS ONE, 2012
• Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy
  American Journal of Physiology-Renal Physiology, 2012
• Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury
  American Journal of Physiology-Renal Physiology, 2011
• Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice
  Kidney International, 2011
• Blocking ERK‐1/2 reduces tumor necrosis factor α–induced interleukin‐18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin‐18 binding protein A
  Arthritis & Rheumatism, 2010
• Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain
  Journal of Neuroimmunology, 2009
• Glomerular 20-HETE, EETs, and TGF-β1 in diabetic nephropathy
  American Journal of Physiology-Renal Physiology, 2009
• The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases
  Arthritis Research & Therapy, 2009
• The Role of Inflammatory Cytokines in Diabetic Nephropathy
  Journal of the American Society of Nephrology, 2008